樂迦再生科技股份有限公司 is a leading brand in the field of cell therapy and regenerative medicine. With a team led by Dr. Ho Hong-Neng, the former president of Taipei Medical University Hospital, and in collaboration with HITACHI and Minaris, the largest CDMO service provider in the cell therapy industry, 樂迦再生 aims to establish a state-of-the-art cell manufacturing facility in Hsinchu Biomedical Science Park that complies with PIC/S GMP standards.

特unning on an international perspective of Taiwan-Japan partnership, 樂迦再生 is dedicated to providing CDMO services for both domestic and international cell therapy companies. By leveraging their expertise in advanced cell therapy products and technology from overseas, as well as Taiwan's abundant clinical resources, 樂迦再生 aims to create the largest cell therapy factory in Asia. Their mission is to contribute to the global regenerative medicine supply chain and collaborate with Taiwan's biotechnology industry to achieve great accomplishments.

For more information, you can contact 樂迦再生科技股份有限公司 at +886-2-2697-2560 or email them at [email protected].